Pathomechanisms and therapeutic opportunities in radiation-induced heart disease: from bench to bedside.

Molecular pathomechanisms of radiation-induced heart disease Onco-cardiology Prevention and therapy of radiation-induced heart disease Radiation heart sequelae

Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 29 10 2020
accepted: 16 01 2021
pubmed: 17 2 2021
medline: 20 11 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

Cancer management has undergone significant improvements, which led to increased long-term survival rates among cancer patients. Radiotherapy (RT) has an important role in the treatment of thoracic tumors, including breast, lung, and esophageal cancer, or Hodgkin's lymphoma. RT aims to kill tumor cells; however, it may have deleterious side effects on the surrounding normal tissues. The syndrome of unwanted cardiovascular adverse effects of thoracic RT is termed radiation-induced heart disease (RIHD), and the risk of developing RIHD is a critical concern in current oncology practice. Premature ischemic heart disease, cardiomyopathy, heart failure, valve abnormalities, and electrical conduct defects are common forms of RIHD. The underlying mechanisms of RIHD are still not entirely clear, and specific therapeutic interventions are missing. In this review, we focus on the molecular pathomechanisms of acute and chronic RIHD and propose preventive measures and possible pharmacological strategies to minimize the burden of RIHD.

Identifiants

pubmed: 33591377
doi: 10.1007/s00392-021-01809-y
pii: 10.1007/s00392-021-01809-y
pmc: PMC8055626
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-531

Subventions

Organisme : Hungarian Scientific Research Fund
ID : FK129094
Organisme : Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
ID : GINOP-2.3.2-15-2016-00040
Organisme : Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
ID : EFOP-3.6.2-16-2017-00006 (LIVE LONGER)
Organisme : Emberi Eroforrások Minisztériuma
ID : ÚNKP-20-5-SZTE-166
Organisme : Emberi Eroforrások Minisztériuma
ID : ÚNKP-20-4-SZTE-150
Organisme : Emberi Eroforrások Minisztériuma
ID : UNKP-19-3-SZTE-159
Organisme : Emberi Eroforrások Minisztériuma
ID : UNKP-19-3-SZTE-160
Organisme : Magyar Tudományos Akadémia
ID : Bolyai János Kutatási Ösztöndíj

Références

Front Physiol. 2018 Nov 26;9:1648
pubmed: 30534079
Lancet Oncol. 2005 Aug;6(8):557-65
pubmed: 16054566
Radiother Oncol. 2017 May;123(2):299-305
pubmed: 28365142
J Clin Oncol. 1993 Jul;11(7):1208-15
pubmed: 8315419
J Radiat Res. 2012;53(1):10-7
pubmed: 22302041
Eur J Pharmacol. 2020 Jan 5;866:172818
pubmed: 31758940
Am J Physiol Heart Circ Physiol. 2017 Nov 1;313(5):H934-H945
pubmed: 28822966
J Am Coll Cardiol. 2003 Aug 20;42(4):743-9
pubmed: 12932613
J Clin Oncol. 2018 Aug 1;36(22):2288-2296
pubmed: 29791285
Radiat Oncol. 2017 Mar 21;12(1):57
pubmed: 28320471
PLoS One. 2015 Mar 23;10(3):e0119661
pubmed: 25799423
Mutat Res. 2016 Oct - Dec;770(Pt B):319-327
pubmed: 27919338
Biochem Biophys Res Commun. 2011 Nov 4;414(4):750-5
pubmed: 22001926
Clin Oncol (R Coll Radiol). 2015 Nov;27(11):621-9
pubmed: 26133462
Hypertension. 2003 Dec;42(6):1164-70
pubmed: 14581293
Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1226-32
pubmed: 18178715
Radiat Res. 2016 Aug;186(2):153-61
pubmed: 27387862
Int J Radiat Biol. 2002 Mar;78(3):219-25
pubmed: 11869477
Mediators Inflamm. 1997;6(3):185-93
pubmed: 18472819
Cardiovasc Ther. 2015 Aug;33(4):168-76
pubmed: 25903419
PLoS One. 2013 Jul 22;8(7):e68762
pubmed: 23894340
Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):595-604
pubmed: 30385276
Eur Heart J Cardiovasc Imaging. 2015 May;16(5):466-70
pubmed: 25744342
Medicina (Kaunas). 2019 May 09;55(5):
pubmed: 31075882
Int J Mol Sci. 2019 Dec 25;21(1):
pubmed: 31881743
Front Cardiovasc Med. 2020 Feb 21;7:20
pubmed: 32154269
Am J Cardiol. 2013 Nov 15;112(10):1688-96
pubmed: 24012026
Biochem Biophys Res Commun. 2016 Oct 28;479(4):847-852
pubmed: 27687548
J Radiat Res. 2016 Sep;57(5):439-448
pubmed: 27422929
Cancer Lett. 2012 Dec 31;327(1-2):48-60
pubmed: 22182453
Radiat Res. 2016 Nov;186(5):478-488
pubmed: 27841740
Radiat Environ Biophys. 2017 Mar;56(1):63-77
pubmed: 28025714
Front Cell Dev Biol. 2020 Mar 12;8:140
pubmed: 32226786
Pharmacol Res. 2016 Sep;111:859-866
pubmed: 27480202
PLoS One. 2015 Sep 02;10(9):e0137337
pubmed: 26332771
Can J Physiol Pharmacol. 2017 Oct;95(10):1190-1203
pubmed: 28750189
Front Cardiovasc Med. 2018 Jul 09;5:83
pubmed: 30038908
Radiother Oncol. 2015 Jan;114(1):96-103
pubmed: 25465731
Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1228-34
pubmed: 15001267
Radiat Res. 2015 Mar;183(3):357-66
pubmed: 25710576
Int J Cardiol. 1993 May;39(2):151-6
pubmed: 8314649
Oncotarget. 2018 Apr 20;9(30):21580-21612
pubmed: 29765562
CA Cancer J Clin. 2016 Jul;66(4):337-50
pubmed: 26891458
Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H392-H407
pubmed: 28550173
Med Hypotheses. 2009 Mar;72(3):263-6
pubmed: 19095366
Methods Mol Biol. 2015;1292:205-14
pubmed: 25804758
Circ Heart Fail. 2018 Aug;11(8):e004867
pubmed: 30354563
J Clin Oncol. 2017 May 20;35(15):1641-1649
pubmed: 28319436
Clin Oncol (R Coll Radiol). 2013 Oct;25(10):617-24
pubmed: 23876528
Radiat Res. 2015 Dec;184(6):611-20
pubmed: 26579943
Radiology. 1980 Feb;134(2):533-5
pubmed: 7352245
J Am Heart Assoc. 2014 Oct 23;3(5):e000773
pubmed: 25341890
Med Hypotheses. 2018 Feb;111:58-60
pubmed: 29406998
Cancer Metastasis Rev. 2004 Aug-Dec;23(3-4):311-22
pubmed: 15197331
Radiother Oncol. 2009 Sep;92(3):492-9
pubmed: 19615773
Breast Cancer. 2020 Mar;27(2):299-307
pubmed: 31707586
Int J Oncol. 2016 Dec;49(6):2217-2226
pubmed: 27748893
Breast J. 2020 Jul;26(7):1308-1315
pubmed: 31876106
J Radiat Res. 2018 Sep 1;59(5):555-564
pubmed: 30010837
Front Genet. 2019 Mar 08;10:205
pubmed: 30906315
Int J Cardiol. 2019 Jun 15;285:72-79
pubmed: 30904281
Cardiovasc Res. 2009 Jul 15;83(2):303-12
pubmed: 19293247
Oncology (Williston Park). 2001 Oct;15(10):1349-54; discussion 1357-60
pubmed: 11702962
Cancer Res. 1996 Nov 15;56(22):5150-5
pubmed: 8912850
Pharmacol Ther. 2019 Dec;204:107399
pubmed: 31419518
J Cardiovasc Pharmacol. 2013 Sep;62(3):247-54
pubmed: 23743768
J Am Coll Cardiol. 2004 Apr 21;43(8):1445-52
pubmed: 15093882
Int J Mol Med. 2018 Nov;42(5):2849-2858
pubmed: 30226567
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Oncologist. 2007 Jun;12(6):738-47
pubmed: 17602063
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2604-9
pubmed: 20133784
Oncogene. 2003 Feb 6;22(5):761-8
pubmed: 12569369
JACC Basic Transl Sci. 2018 Dec 31;3(6):861-870
pubmed: 30623145
Radiat Res. 2000 May;153(5 Pt 1):540-7
pubmed: 10790275
In Vivo. 2016 09-10;30(5):623-31
pubmed: 27566082
PLoS One. 2013;8(2):e57052
pubmed: 23451141
Circulation. 2013 Oct 22;128(17):1927-95
pubmed: 24081971
Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):32-9
pubmed: 25863751
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):911-20
pubmed: 26104943
Br J Cancer. 2018 Aug;119(4):408-418
pubmed: 30065254
Int J Radiat Biol. 2003 Nov;79(11):889-96
pubmed: 14698957
Endocrinology. 2013 Apr;154(4):1624-35
pubmed: 23417421
Clin Exp Pharmacol Physiol. 2010 Nov;37(11):1055-63
pubmed: 20659133
Eur Heart J. 2016 Jun 1;37(21):1671-80
pubmed: 26903532
J Am Coll Cardiol. 2017 Nov 14;70(20):2552-2565
pubmed: 29145955
J Am Coll Cardiol. 2013 Jun 11;61(23):2319-28
pubmed: 23583253
Hypertension. 2012 Jan;59(1):136-44
pubmed: 22068875
Radiother Oncol. 2015 Nov;117(2):376-81
pubmed: 26233589
BMC Med Inform Decis Mak. 2019 Oct 29;19(1):204
pubmed: 31664991
Biomed Pharmacother. 2019 Oct;118:109217
pubmed: 31302424
Int J Radiat Biol. 1992 Feb;61(2):149-60
pubmed: 1351901
Am J Physiol Cell Physiol. 2007 Feb;292(2):C867-75
pubmed: 16987994
Int J Mol Sci. 2018 Apr 10;19(4):
pubmed: 29642568
Cancer Metastasis Rev. 2018 Sep;37(2-3):213-225
pubmed: 29971572
Pacing Clin Electrophysiol. 1991 Jul;14(7):1112-8
pubmed: 1715548
J Cell Mol Med. 2011 May;15(5):1148-55
pubmed: 20518847
Oxid Med Cell Longev. 2016;2016:3863726
pubmed: 26788247
J Cardiol. 2019 Oct;74(4):313-319
pubmed: 31202488
Cells. 2019 Sep 18;8(9):
pubmed: 31540530
Cardiovasc Res. 2006 Feb 15;69(3):726-35
pubmed: 16165109
Physiol Res. 2016 Sep 19;65 Suppl 1:S129-37
pubmed: 27643935
J Mol Cell Cardiol. 2018 Mar;116:125-134
pubmed: 29426003
Acta Oncol. 2014 Jan;53(1):58-64
pubmed: 23544358
Ann Oncol. 2010 Sep;21(9):1825-1833
pubmed: 20211871
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):559-63
pubmed: 22203988
Radiother Oncol. 2011 Aug;100(2):160-6
pubmed: 20826032
J Mol Med (Berl). 2013 Nov;91(11):1257-71
pubmed: 23955016
Circulation. 2011 May 24;123(20):2226-35
pubmed: 21555710
Circulation. 1982 May;65(5):924-7
pubmed: 7074754
J Mol Cell Cardiol. 2005 Nov;39(5):833-40
pubmed: 16171809
Circ Res. 2000 Mar 17;86(5):580-8
pubmed: 10720420
Atherosclerosis. 2004 Jul;175(1):59-67
pubmed: 15186947
Eur Heart J. 2019 Aug 7;40(30):2495-2503
pubmed: 31081038
Anticancer Res. 2019 Apr;39(4):1667-1673
pubmed: 30952705
J Am Coll Cardiol. 2019 Aug 20;74(7):905-927
pubmed: 31416535
Semin Radiat Oncol. 2003 Jul;13(3):346-56
pubmed: 12903022
Curr Oncol Rep. 2018 Apr 11;20(6):45
pubmed: 29644475
Adv Radiat Oncol. 2019 Jan 30;4(2):246-252
pubmed: 31011669
Front Cardiovasc Med. 2020 Feb 21;7:16
pubmed: 32154267
J Radiat Res. 2020 Sep 8;61(5):657-665
pubmed: 32642776
J Natl Cancer Inst. 2015 Feb 23;107(4):
pubmed: 25713164
Peptides. 2006 Jan;27(1):87-94
pubmed: 16095757
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
Radiother Oncol. 2011 Aug;100(2):184-8
pubmed: 21497931
PLoS One. 2015 Apr 10;10(4):e0122511
pubmed: 25860286
Drug Discov Today. 2013 Sep;18(17-18):836-42
pubmed: 23384772
Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1552-9
pubmed: 19306752
J Clin Oncol. 2017 Apr 10;35(11):1171-1178
pubmed: 28095159
J Clin Invest. 2002 Mar;109(6):787-96
pubmed: 11901187
Radiother Oncol. 2011 Aug;100(2):167-75
pubmed: 21752480
Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1553-61
pubmed: 19931737
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):980-7
pubmed: 19251085
Am J Transl Res. 2019 Oct 15;11(10):6585-6599
pubmed: 31737210
Circ Res. 2004 Mar 5;94(4):534-41
pubmed: 14699015
J Natl Cancer Inst. 2017 Aug 1;109(8):
pubmed: 28376190
PLoS One. 2019 May 31;14(5):e0217443
pubmed: 31150454
Front Oncol. 2015 Feb 18;5:39
pubmed: 25741474
Front Oncol. 2019 Jul 16;9:598
pubmed: 31380269
Drug Discov Today. 2016 Apr;21(4):654-62
pubmed: 26955911
Radiat Oncol. 2016 Apr 27;11:61
pubmed: 27117590
Oncogene. 2003 Sep 1;22(37):5734-54
pubmed: 12947383
J Clin Oncol. 2016 Jan 20;34(3):235-43
pubmed: 26573075
Radiother Oncol. 2010 Oct;97(1):149-61
pubmed: 20888056
Circ Res. 2004 Jan 9;94(1):37-45
pubmed: 14656924
Toxicol Lett. 2018 Mar 15;285:74-80
pubmed: 29305325
Acta Oncol. 2003;42(1):4-9
pubmed: 12665324
Peptides. 2014 Feb;52:104-12
pubmed: 24373935
Arch Biochem Biophys. 1997 Jun 15;342(2):261-74
pubmed: 9186487
Int J Cardiol. 1996 Dec 13;57(3):289-91
pubmed: 9024919
Hum Exp Toxicol. 2017 Nov;36(11):1121-1130
pubmed: 27932539
Int J Biol Sci. 2019 Aug 8;15(10):2128-2138
pubmed: 31592122
Int J Radiat Biol. 2014 Apr;90(4):284-90
pubmed: 24467328
Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):170-7
pubmed: 18632215
Oncogene. 2009 Nov 19;28(46):4041-52
pubmed: 19802002
Clin Res Cardiol. 2020 Oct;109(10):1197-1222
pubmed: 32405737
Radiother Oncol. 2018 Apr;127(1):1-5
pubmed: 29605476
J Intern Med. 2011 May;269(5):469-77
pubmed: 21255133
N Engl J Med. 2015 Jul 2;373(1):96
pubmed: 26132959
Radiother Oncol. 2018 Mar;126(3):487-492
pubmed: 29373194
Bratisl Lek Listy. 2018;119(1):54-59
pubmed: 29405732
Biochim Biophys Acta. 2013 Dec;1833(12):3448-3459
pubmed: 23770045
Br J Pharmacol. 2007 Sep;152(2):189-205
pubmed: 17592511
Postgrad Med J. 1986 Nov;62(733):1055-8
pubmed: 3628154
Int J Nanomedicine. 2020 May 27;15:3741-3769
pubmed: 32547026
World J Cardiol. 2016 Sep 26;8(9):504-519
pubmed: 27721934
Am J Clin Oncol. 2017 Apr;40(2):133-139
pubmed: 25268066
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
J Am Coll Cardiol. 2017 Jul 11;70(2):252-289
pubmed: 28315732
Am J Pathol. 2008 Jul;173(1):2-13
pubmed: 18535182

Auteurs

Márta Sárközy (M)

MEDICS Research Group, Department of Biochemistry, Interdisciplinary Center of Excellence, University of Szeged, Szeged, 6720, Hungary. sarkozy.marta@med.u-szeged.hu.

Zoltán Varga (Z)

Department of Oncotherapy, Faculty of Medicine, University of Szeged, Szeged, 6720, Hungary.

Renáta Gáspár (R)

MEDICS Research Group, Department of Biochemistry, Interdisciplinary Center of Excellence, University of Szeged, Szeged, 6720, Hungary.

Gergő Szűcs (G)

MEDICS Research Group, Department of Biochemistry, Interdisciplinary Center of Excellence, University of Szeged, Szeged, 6720, Hungary.

Mónika G Kovács (MG)

MEDICS Research Group, Department of Biochemistry, Interdisciplinary Center of Excellence, University of Szeged, Szeged, 6720, Hungary.

Zsuzsanna Z A Kovács (ZZA)

MEDICS Research Group, Department of Biochemistry, Interdisciplinary Center of Excellence, University of Szeged, Szeged, 6720, Hungary.

László Dux (L)

Department of Biochemistry, Faculty of Medicine, University of Szeged, Szeged, H-6720, Hungary.

Zsuzsanna Kahán (Z)

Department of Oncotherapy, Faculty of Medicine, University of Szeged, Szeged, 6720, Hungary. kahan.zsuzsanna@med.u-szeged.hu.

Tamás Csont (T)

MEDICS Research Group, Department of Biochemistry, Interdisciplinary Center of Excellence, University of Szeged, Szeged, 6720, Hungary. csont.tamas@med.u-szeged.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH